International Cannabis Weekly: 454

LISTED: CANNABIS FINALLY CRACKS AMERICA’S MAJOR EXCHANGES

Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.

READ MORE  »

FRANCE SETS JULY DEADLINE FOR MEDICAL CANNABIS REGULATIONS

READ MORE »

EU CANNABIS INSIGHTS SUMMIT 2026: PATIENTS & POLITICS POST-RECLASSIFICATION

READ MORE »

• Remexian CEO says Portuguese cannabis flower meets excellent pharmaceutical quality standards.
• Remexian Pharma showcases exclusive Canadian medical cannabis partnerships at Mary Jane Berlin 2026.
• Partnership with Astrasana: Sanity Group expands activities in the Swiss medical cannabis market.
• Spanish cannabis grower wins cultivation licence and targets UK and German markets.
• EnWave targets Europe’s cannabis market through new Swiss commercial trial initiative.
• EU-funded project highlights long hemp fibre potential for high-performance composite materials.

LEARN MORE »

• South Carolina Republican governor candidates signal openness to signing medical cannabis legislation.
• Virginia leaders reach agreement to establish a regulated adult-use cannabis retail market.
• InterCure completes Botanico acquisition and expands its medical cannabis footprint in the United States.
• Vireo Growth moves to acquire C21 Investments and expand Nevada cannabis operations.
• Glass House Brands announces business deconsolidation and plans for NYSE uplisting.
• State hemp policy developments continue across Delaware Illinois Michigan and Ohio.
• Tribal cannabis businesses continue expanding their presence across the United States.
• InterCure initiates review of US medical cannabis opportunities following federal rescheduling.

• SQDC has surpassed C$800 million in its annual cannabis sales during the whole of 2025.
• High Tide has reported record second-quarter revenue and adjusted EBITDA growth.
• A veterans cannabis policy has generated an estimated C$4.4 billion in savings, report reveals.
• Aurora cannabis generates 55% revenue outside Canada as medical sales surge – quarterly update report.
• Canopy Growth earnings call focuses on path toward sustainable EBITDA performance.
• Ontario regulator is in the process of investigating SNDL retail holdings amid expansion concerns.
• A Toronto-based  cannabis retailer has gained attention after receiving FIFA legal notice.

• Green Med accelerates regional expansion with pharmaceutical cannabis platform focused on Brazil.
• Argentinian province creates advisory council to advance medical cannabis policy development.
• Ten years after regulation Uruguay seeks to integrate medical cannabis into healthcare system.

• Chinese-backed fiber venture, planned hemp block maker win $6.5M grants in Australia.
• Australian funding support Khalifa Kush officially enters the Australian medical cannabis market.
• Australian government considers mandatory My Health Record reporting for telehealth clinics.

• South Africa’s legal cannabis market outlook highlights growth opportunities and challenges.
• InterCure completes first Botanico acquisition tranche to strengthen international medical cannabis platform.